MRCEM Notes

Hypersensitivity reactions

On this page
Hypersensitivity reactions are abnormal immune-mediated responses that cause tissue damage. They may target exogenous antigens (environmental) or self-antigens (autoimmunity).

They are classified by Gell and Coombs into four types* (I–IV).

Summary table: hypersensitivity reactions
TypeDescriptionMediatorsExamples
Type 1Allergy (immediate)IgEAnaphylaxis
Atopy
Asthma
Type 2Cytotoxic / Antibody dependentIgG
IgM
Compliment
MAC
Autoimmune haemolytic aenamia
Goodpastures syndrome
Thrombocytopenia
Graves disease*
Myasthenia gravis*
Type 3Immune complex mediatedIgG
IgM
Compliment
Neutrophils
SLE
Rheumatoid arthritis
Post streptococcal glomerulonephritis
Type 4Delayed hypersensitivity reactionsT-cellsContact Dermatitis
Mantoux test
Multiple Sclerosis

*Some people use a Coombs & Gell 5 type classification. Type V reactions are a subtype of Type 2 reactions where autoimmune reactions involve the antibodies reacting with cell surface receptors e.g. Graves and Myasthenia Gravis.



Type I – Immediate (IgE-mediated)


Mechanism:

  • Sensitisation phase involving initial antigen exposure which activates B cells to overproduce IgE. IgE binds Fc receptors on mast cells and basophils, coating them.
  • Subsequent exposure results in allergen antigens cross-linking with surface IgE leading to degranulation of mast cells/basophils which release histamine, leukotrienes and prostaglandins.
  • Late-phase response see's eosinophils recruited causing ongoing inflammation hours after exposure.

Onset: Minutes (early) to hours (late).

Clinical examples:
  • Allergic rhinitis
  • Allergic conjunctivitis
  • Asthma (allergic type)
  • Urticaria
  • Angioedema
  • Systemic anaphylaxis
  • Penicillin allergy



Type II – Cytotoxic (antibody-mediated)

Mechanism:

  • IgG or IgM antibodies bind cell surface antigens (foreign or self).
  • Cell destruction occurs via complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC) and phagocytosis

Onset: Hours to days.

Clinical examples:
  • Incompatible blood transfusions
  • Haemolytic disease of the newborn
  • Autoimmune haemolytic anaemia (AIHA)
  • Goodpasture’s syndrome
  • Rheumatic heart disease
  • Bullous pemphigoid
  • Myasthenia gravis
  • Graves’ disease



Type III – Immune complex-mediated

Mechanism:
  • IgG (or IgM) antibodies bind soluble antigens and form immune complexes.
  • Normally cleared by complement opsonization and phagocytosis in the spleen.
  • Excess antigen or impaired clearance leads to immune complex deposition in tissues triggering complement activation and neutrophil recruitment which results in inflammation and tissue damage.

Predilection sites: Small blood vessels, kidneys, joints.

Onset: Hours to days.

Clinical examples:
  • Systemic lupus erythematosus (SLE)
  • Post-streptococcal glomerulonephritis
  • Serum sickness
  • Arthus reaction
  • Extrinsic allergic alveolitis
  • Rheumatoid arthritis
  • Reactive arthritis



Type IV – Delayed-type (T-cell-mediated)

Mechanism:

  • On first exposure antigen activates T helper (Th1) cells leading to clonal expansion (1–2 weeks).
  • On subsequent exposure sensitised T cells release cytokines, recruit and activate macrophages leading to tissue injury.
  • CD8+ T cells also directly kill target cells.

Onset: 48–72 hours.

Clinical examples:
  • Contact dermatitis (e.g., poison ivy, nickel)
  • Tuberculin skin test (Mantoux)
  • Hashimoto’s thyroiditis
  • Chronic transplant rejection
  • Granulomatous inflammation (sarcoidosis, Crohn’s disease)
  • Primary biliary cholangitis
  • Type 1 diabetes

Mnemonic to Remember Types
ACID:
  • A = Anaphylaxis / Allergic (Type I)
  • C = Cytotoxic (Type II)
  • I = Immune complex (Type III)
  • D = Delayed (Type IV)
Full-size image